Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability of Alprazolam Tablets, 2 mg.

NCT00912145 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT00912145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00912145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability of Alprazolam Tablets, 2 mg.
Lead sponsor
Sandoz
Phase
Phase 1
Overall status
Completed
Start date
February 29, 1996
Completion date
February 29, 1996
Enrollment
26 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety